These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 30051930)

  • 1. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
    Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
    Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
    Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
    J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rate of infantile hemangioma after oral propranolol therapy.
    Frongia G; Byeon JO; Mehrabi A; Günther P
    Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile hemangiomas: what have we learned from propranolol?
    Hagen R; Ghareeb E; Jalali O; Zinn Z
    Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.